top of page

SR One's Simeon George on recent news from CRISPR, Turning Point (Bristol), Arcellx, and more

Simeon George talks about his firm's philosophy, advice for biotech entrepreneurs, and discusses Turning Point, Avenzo, CRISPR, Nkarta, Arcellx, ADARx, and Rezo Therapeutics.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page